Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001562180-24-006086
Filing Date
2024-08-07
Accepted
2024-08-07 16:04:41
Documents
2
Period of Report
2024-08-05

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primarydocument.html 4  
1 PRIMARY DOCUMENT primarydocument.xml 4 5384
2 POA2024 cbennechipoa.txt EX-24 1829
  Complete submission text file 0001562180-24-006086.txt   8646
Mailing Address 215 FIRST STREET CAMBRIDGE MA 02142
Business Address 215 FIRST STREET CAMBRIDGE MA 02142 617-299-8380
Sage Therapeutics, Inc. (Issuer) CIK: 0001597553 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O SAGE THERAPEUTICS, INC. 215 FIRST STREET CAMBRIDGE MA 02142
Business Address
Benecchi Christopher (Reporting) CIK: 0001881403 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36544 | Film No.: 241183528